# Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization

> **NCT07675473** · PHASE4 · RECRUITING · sponsor: **Long Jiang** · enrollment: 150 (estimated)

## Conditions studied

- Lung Nodules

## Interventions

- **DRUG:** PARECOXIB SODIUM
- **DRUG:** 0.9 % Normal Saline

## Key facts

- **NCT ID:** NCT07675473
- **Lead sponsor:** Long Jiang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675473, "Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*